Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: Implications for the regulation of granulopoiesis

Blood

Volumn 101, Issue 5, 2003, Pages 1752-1758

  El Ouriaghli, Frank ^a   Fujiwara, Hiroshi ^a   Metenhorst, J Joseph ^a   Sconocchia, Giuseppe ^a   Hensel, Nancy ^a   Barrett, A John ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; LEUKOCYTE ELASTASE;

ARTICLE; CELL MATURATION; CELL PROLIFERATION; CELL SUSPENSION; COLONY FORMING UNIT; ENZYME INHIBITION; ENZYME REGULATION; GRANULOPOIESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DEGRADATION; STEM CELL;

EID: 0037370710     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1734     Document Type: Article

References (30)

1. Boxer L, Dale DC. Neutropenia: causes and consequences. Semin Hematol. 2002;39:75-81.
2. Lieschke GJ, Grail D, Hodgson G, et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994;84:1737-1746.
3. Hammond WP, Csiba E, Canin A, et al. Chronic neutropenia: a new canine model induced by human granulocyte colony-stimulating factor. J Clin Invest. 1991;87:704-710.
4. + peripheral blood mononuclear cells from chronic myeloid leukemia and normal donors are inhibitory to short- and long-term cultured colony-forming cells. Leuk Res. 2000;24:217-231.
5. Rytomaa T. Role of chalone in granulopoiesis. Br J Haematol. 1973;24:141-146.
6. Broxmeyer HE, Smithyman A, Eger RR, Meyers PA, de Sousa M. Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production. J Exp Med. 1978;148:1052-1067.
7. Skold S, Rosberg B, Gullberg U, Olofsson T. A secreted proform of neutrophil proteinase 3 regulates the proliferation of granulopoietic progenitor cells. Blood. 1999;93:849-856.
8. Skold S, Zeberg L, Gullberg U, Olofsson T. Functional dissociation between proforms and mature forms of proteinase 3, azurocidin, and granzyme B in regulation of granulopoiesis. Exp Hematol. 2002;30:689-696.
9. Shellard JE, Leitch HA, Logan PM, McMaster WR, Levy JG. Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL). Exp Hematol. 1991;19:136-142.
10. Leitch HA, Yip ST, Jamieson CH, Levy JG. Inhibition of murine hematopoiesis by CAMAL, an inhibitor of human hematopoiesis. Leukemia. 1993;7:717-724
11. Leitch HA, Levy JG. Reversal of CAMAL-mediated alterations of normal and leukemic in vitro myelopoiesis using inhibitors of proteolytic activity. Leukemia. 1994;8:605-611.
12. Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet. 1999;23:433-436.
13. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000;96:2317-2322.
14. Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood. 2001;98:1289-1297.
15. Koller MR, Bradley MS, Palsson BO. Growth factor consumption and production in perfusion cultures of human bone marrow correlate with specific cell production. Exp Hematol. 1995;23:1275-1283.
16. Larsen A, Davis T, Curtis BM, et al. Expression cloning of a human granulocyte - colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains. J Exp Med. 1990;172:1559-1570.
17. McDonald JA, Kelley DG. Degradation of fibronectin by human leukocyte elastase: release of biologically active fragments. J Biol Chem. 1980;255:8848-8858.
18. Nagamatsu Y, Yamamoto J, Fukuda A, Ohta M, Tsuda Y, Okada Y. Determination of leukocyte elastase concentration in plasma and serum by a simple method using a specific synthetic substrate. Haemostasis. 1991;21:338-345.
19. Renesto P, Chignard M. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation. Blood. 1993;82:139-144.
20. Falanga A, Marchetti M, Evangelista V, et al. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor. Blood. 1999;93:2506-2514.
21. Layton JE, Hockman H, Sheridan WP, Morstyn G. Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor. Blood. 1989;74:1303-1307.
22. Stute N, Santana VM, Rodman JH, Schell MJ, Ihle JN, Evans WE. Pharmacokinetics of subcutaneous recombinant human granulocyte - colony-stimulating factor in children. Blood. 1992;79:2849-2854.
23. Ericson SG, Gao H, Gericke GH, Lewis LD. The role of polymorphonuclear neutrophils in clearance of granulocyte - colony-stimulating factor (G-CSF) in vivo and in vitro. Exp Hematol. 1997;25:1313-1325.
24. Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 2000;12:201-210.
25. Belaaouai A, McCarthy R, Baumann M, et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med. 1998;5:615-618.
26. Dale DC, Bolyard AA, Aprikyan A. Cyclic neutropenia. Semin Hematol. 2002;39:89-94.
27. Li FQ, Horwitz M. Characterization of mutant neutrophil elastase in severe congenital neutropenia. J Biol Chem. 2001;276:14230-14241.
28. Ancliff PJ, Gale RE, Watts MJ, et al. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood. 2002;100:707-709.
29. Hiller E, Jochum M. Plasma levels of human granulocytic elastase α 1-proteinase inhibitor complex (E-α 1-Pl) in leukemia. Blut. 1984;48:269-275.
30. Saito M, Asakura H, Uotani C, Jokaji H, Kumabashiri I, Matsuda T. Quantitative estimation of elastase-α 1-proteinase inhibitor (E-α 1 Pl) complex in leukemia: marked elevation in cases of acute promyelocytic leukemia. Thromb Res. 1989;53:163-171.